Susan Levinson ^UDM

Susan Levinson is the Founder and Board Member of Azure Biotech Inc., a pioneering biotechnology company specializing in womens health through innovative formulations of lasofoxifene. With a robust career spanning several decades, she previously served as the Chief Executive Officer of BioAegis Therapeutics, Inc., where she led the development of therapeutics aimed at modulating inflammation and enhancing immune function. Levinsons extensive experience in the pharmaceutical industry includes key roles at Novartis Pharmaceuticals and Ciba-Geigy, where she was instrumental in strategic planning, product commercialization, and licensing initiatives. Currently, she contributes her expertise as a member of the Board of Trustees at BioNJ, advocating for the growth of the biotechnology sector in New Jersey. Levinson holds a PhD in Biomedical Sciences from the Icahn School of Medicine at Mount Sinai and a BS in Biochemistry from the University of Wisconsin-Madison. Her professional journey reflects a commitment to advancing healthcare through innovative solutions and strategic leadership.